Sesquiterpene lactones as potential therapeutic agents against Naegleria fowleri

Naegleria fowleri is the causative agent the primary amoebic meningoencephalitis (PAM), a fatal disease in more than the 90% of the reported cases that affects the central nervous system. The amoeba infects the nasal cavity of mostly children and young adults who report previous aquatic exposure in warm water sources. The rapid progression of the disease and the lack of effective and safety therapeutic options make the search of new anti-amoebic compounds an urgent issue. In this study, twelve sesquiterpene lactones isolated from the zoanthid Palythoa aff. clavata were tested against the trophozoite stage of Naegleria fowleri. Anhydroartemorin (2) and 1(10)Z,4E,14-acetoxy-costunolide (3) showed the best anti-amoeboid activity values with IC50 23.02 ± 1.26 and 28.34 ± 6.27, respectively. In addition, the mechanisms of programmed cell death induction of these two molecules were evaluated with positive results for both compounds. Finally, a structure-activity relationship was analyzed to reveal the dependence of reactivity and lipophilicity on the biological activity. The log P values of the compounds were calculated to postulate them as good candidates to cross the blood-brain barrier, a limiting factor in the development of new anti-Naegleria treatments. Therefore, the mentioned sesquiterpene lactones could be considered as potential PAM therapeutic options in the future.

Saved in:
Bibliographic Details
Main Authors: Arberas-Jiménez, Íñigo, Rizo-Liendo, Aitor, Nocchi, Nathália, Sifaoui, Inés, Chao-Pellicer, Javier, Souto, María L., Suárez-Gómez, Blanca, DIAZ MARRERO, ANA RAQUEL, Fernández, José J., Piñero, José E., Lorenzo-Morales, Jacob
Other Authors: Instituto de Salud Carlos III
Format: artículo biblioteca
Language:English
Published: Elsevier BV 2022-02-05
Subjects:Naegleria, Palythoa, sesquiterpene lactones, meningoencephalitis, programmed cell death,
Online Access:http://hdl.handle.net/10261/303074
http://dx.doi.org/10.13039/501100007757
http://dx.doi.org/10.13039/501100011033
http://dx.doi.org/10.13039/501100000780
http://dx.doi.org/10.13039/501100004587
http://dx.doi.org/10.13039/501100004837
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-ipna-es-10261-303074
record_format koha
spelling dig-ipna-es-10261-3030742023-03-15T02:43:19Z Sesquiterpene lactones as potential therapeutic agents against Naegleria fowleri Arberas-Jiménez, Íñigo Rizo-Liendo, Aitor Nocchi, Nathália Sifaoui, Inés Chao-Pellicer, Javier Souto, María L. Suárez-Gómez, Blanca DIAZ MARRERO, ANA RAQUEL Fernández, José J. Piñero, José E. Lorenzo-Morales, Jacob Instituto de Salud Carlos III Ministerio de Ciencia e Innovación (España) Agencia Estatal de Investigación (España) Ministerio Español de Salud European Commission Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (España) Cabildo de Tenerife Agencia Canaria de Investigación, Innovación y Sociedad de la Información Naegleria Palythoa sesquiterpene lactones meningoencephalitis programmed cell death Naegleria fowleri is the causative agent the primary amoebic meningoencephalitis (PAM), a fatal disease in more than the 90% of the reported cases that affects the central nervous system. The amoeba infects the nasal cavity of mostly children and young adults who report previous aquatic exposure in warm water sources. The rapid progression of the disease and the lack of effective and safety therapeutic options make the search of new anti-amoebic compounds an urgent issue. In this study, twelve sesquiterpene lactones isolated from the zoanthid Palythoa aff. clavata were tested against the trophozoite stage of Naegleria fowleri. Anhydroartemorin (2) and 1(10)Z,4E,14-acetoxy-costunolide (3) showed the best anti-amoeboid activity values with IC50 23.02 ± 1.26 and 28.34 ± 6.27, respectively. In addition, the mechanisms of programmed cell death induction of these two molecules were evaluated with positive results for both compounds. Finally, a structure-activity relationship was analyzed to reveal the dependence of reactivity and lipophilicity on the biological activity. The log P values of the compounds were calculated to postulate them as good candidates to cross the blood-brain barrier, a limiting factor in the development of new anti-Naegleria treatments. Therefore, the mentioned sesquiterpene lactones could be considered as potential PAM therapeutic options in the future. This work was funded by projects PI18/01380 from Instituto de Salud Carlos III, Spain and RICET (RD16/0027/0001 project) and PID2019–109476RB-C21 (BIOALGRI) (Spanish Ministry of Science, Madrid, Spain; from Programa Redes Temáticas de Investigación Cooperativa, FIS (Ministerio Español de Salud, Madrid, Spain) and FEDER. Consorcio Centro de Investigación Biomédica En Red M.P. (CIBER) de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28006 Madrid, Spain and Cabildo de Tenerife 21/0587 cofunded by MEDI and FDCAN. ARL and IAJ were funded by Agencia Canaria de Investigación, Innovación y Sociedad de la Información (ACIISI). N.N. were funded by the Agustín de Betancourt Programme (Cabildo de Tenerife, TFinnova Programme supported by MEDI and FDCAN funds). Authors acknowledge to Drs. Alberto Brito and Adriana Rodríguez Hernández from Universidad de La Laguna (ULL) the taxonomic classification of biological material, and Dr. Ezequiel Quintana Morales from Instituto de Productos Naturales y Agrobiología, Consejo Superior de Investigaciones Científicas (IPNA-CSIC) for assistance in molecular calculations. Peer reviewed 2023-03-14T10:40:38Z 2023-03-14T10:40:38Z 2022-02-05 artículo Biomedicine & Pharmacotherapy, 12(9), 112694: 1-9 (2022) 0753-3322 http://hdl.handle.net/10261/303074 10.1016/j.biopha.2022.112694 http://dx.doi.org/10.13039/501100007757 http://dx.doi.org/10.13039/501100011033 http://dx.doi.org/10.13039/501100000780 http://dx.doi.org/10.13039/501100004587 http://dx.doi.org/10.13039/501100004837 en #PLACEHOLDER_PARENT_METADATA_VALUE# info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2019-109476RB-C21/ES/MOLECULAS BIOACTIVAS DE MICROALGAS MARINAS/ Publisher's version https://doi.org/10.1016/j.biopha.2022.112694 Sí open Elsevier BV
institution IPNA ES
collection DSpace
country España
countrycode ES
component Bibliográfico
access En linea
databasecode dig-ipna-es
tag biblioteca
region Europa del Sur
libraryname Biblioteca del IPNA España
language English
topic Naegleria
Palythoa
sesquiterpene lactones
meningoencephalitis
programmed cell death
Naegleria
Palythoa
sesquiterpene lactones
meningoencephalitis
programmed cell death
spellingShingle Naegleria
Palythoa
sesquiterpene lactones
meningoencephalitis
programmed cell death
Naegleria
Palythoa
sesquiterpene lactones
meningoencephalitis
programmed cell death
Arberas-Jiménez, Íñigo
Rizo-Liendo, Aitor
Nocchi, Nathália
Sifaoui, Inés
Chao-Pellicer, Javier
Souto, María L.
Suárez-Gómez, Blanca
DIAZ MARRERO, ANA RAQUEL
Fernández, José J.
Piñero, José E.
Lorenzo-Morales, Jacob
Sesquiterpene lactones as potential therapeutic agents against Naegleria fowleri
description Naegleria fowleri is the causative agent the primary amoebic meningoencephalitis (PAM), a fatal disease in more than the 90% of the reported cases that affects the central nervous system. The amoeba infects the nasal cavity of mostly children and young adults who report previous aquatic exposure in warm water sources. The rapid progression of the disease and the lack of effective and safety therapeutic options make the search of new anti-amoebic compounds an urgent issue. In this study, twelve sesquiterpene lactones isolated from the zoanthid Palythoa aff. clavata were tested against the trophozoite stage of Naegleria fowleri. Anhydroartemorin (2) and 1(10)Z,4E,14-acetoxy-costunolide (3) showed the best anti-amoeboid activity values with IC50 23.02 ± 1.26 and 28.34 ± 6.27, respectively. In addition, the mechanisms of programmed cell death induction of these two molecules were evaluated with positive results for both compounds. Finally, a structure-activity relationship was analyzed to reveal the dependence of reactivity and lipophilicity on the biological activity. The log P values of the compounds were calculated to postulate them as good candidates to cross the blood-brain barrier, a limiting factor in the development of new anti-Naegleria treatments. Therefore, the mentioned sesquiterpene lactones could be considered as potential PAM therapeutic options in the future.
author2 Instituto de Salud Carlos III
author_facet Instituto de Salud Carlos III
Arberas-Jiménez, Íñigo
Rizo-Liendo, Aitor
Nocchi, Nathália
Sifaoui, Inés
Chao-Pellicer, Javier
Souto, María L.
Suárez-Gómez, Blanca
DIAZ MARRERO, ANA RAQUEL
Fernández, José J.
Piñero, José E.
Lorenzo-Morales, Jacob
format artículo
topic_facet Naegleria
Palythoa
sesquiterpene lactones
meningoencephalitis
programmed cell death
author Arberas-Jiménez, Íñigo
Rizo-Liendo, Aitor
Nocchi, Nathália
Sifaoui, Inés
Chao-Pellicer, Javier
Souto, María L.
Suárez-Gómez, Blanca
DIAZ MARRERO, ANA RAQUEL
Fernández, José J.
Piñero, José E.
Lorenzo-Morales, Jacob
author_sort Arberas-Jiménez, Íñigo
title Sesquiterpene lactones as potential therapeutic agents against Naegleria fowleri
title_short Sesquiterpene lactones as potential therapeutic agents against Naegleria fowleri
title_full Sesquiterpene lactones as potential therapeutic agents against Naegleria fowleri
title_fullStr Sesquiterpene lactones as potential therapeutic agents against Naegleria fowleri
title_full_unstemmed Sesquiterpene lactones as potential therapeutic agents against Naegleria fowleri
title_sort sesquiterpene lactones as potential therapeutic agents against naegleria fowleri
publisher Elsevier BV
publishDate 2022-02-05
url http://hdl.handle.net/10261/303074
http://dx.doi.org/10.13039/501100007757
http://dx.doi.org/10.13039/501100011033
http://dx.doi.org/10.13039/501100000780
http://dx.doi.org/10.13039/501100004587
http://dx.doi.org/10.13039/501100004837
work_keys_str_mv AT arberasjimenezinigo sesquiterpenelactonesaspotentialtherapeuticagentsagainstnaegleriafowleri
AT rizoliendoaitor sesquiterpenelactonesaspotentialtherapeuticagentsagainstnaegleriafowleri
AT nocchinathalia sesquiterpenelactonesaspotentialtherapeuticagentsagainstnaegleriafowleri
AT sifaouiines sesquiterpenelactonesaspotentialtherapeuticagentsagainstnaegleriafowleri
AT chaopellicerjavier sesquiterpenelactonesaspotentialtherapeuticagentsagainstnaegleriafowleri
AT soutomarial sesquiterpenelactonesaspotentialtherapeuticagentsagainstnaegleriafowleri
AT suarezgomezblanca sesquiterpenelactonesaspotentialtherapeuticagentsagainstnaegleriafowleri
AT diazmarreroanaraquel sesquiterpenelactonesaspotentialtherapeuticagentsagainstnaegleriafowleri
AT fernandezjosej sesquiterpenelactonesaspotentialtherapeuticagentsagainstnaegleriafowleri
AT pinerojosee sesquiterpenelactonesaspotentialtherapeuticagentsagainstnaegleriafowleri
AT lorenzomoralesjacob sesquiterpenelactonesaspotentialtherapeuticagentsagainstnaegleriafowleri
_version_ 1777669919968591872